Results 1 to 10 of about 104,440 (209)

Budget Impact Analysis and Its Rational Basis [PDF]

open access: bronzeMedical Decision Making, 2008
T title of the article by Mar and others contains a term that is probably new to many readers. They may be pleased to learn that the term Budget Impact Analysis (BIA) means exactly what it says. A recent report from a task force under ISPOR (International Society for Pharmacoeconomics and Outcomes Research) describes the underlying philosophy and ...
Jørgen Hilden
openalex   +4 more sources

Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis [PDF]

open access: goldJournal of Market Access & Health Policy, 2018
Background: Hard-to-heal wounds are associated with high treatment costs and, in Germany, are mostly treated in the outpatient care sector. Wound dressings are the main cost-drivers in venous leg ulcer (VLU) care which prescription is budget-restricted ...
Maria Gueltzow   +3 more
doaj   +2 more sources

Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis

open access: greenClinicoEconomics and Outcomes Research, 2019
Alberto Migliore,1 Davide Integlia,2 Giuseppe Pompilio,2 Francesca Di Giuseppe,2 Cinzia Aru,2 Tray Brown31Unit of Rheumatology, San Pietro Fatebenefratelli Hospital, Rome, Italy; 2ISHEO Srl, Rome, Italy; 3Department of Public Health and Primary Care ...
Migliore A   +5 more
doaj   +1 more source

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy [PDF]

open access: yesClinicoEconomics and Outcomes Research
Luca Prosperini,1 Lorenzo Pradelli,2 Laura Santoni,3 Daria Perini,3 Salvatore Cottone,4 Marco Vercellino5 1S. Camillo-Forlanini Hospital, Rome, Italy; 2AdRes Health Economics and Outcomes Resources, Turin, Italy; 3Biogen Italia, Milan, Italy; 4Department
Prosperini L   +5 more
doaj   +2 more sources

Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand [PDF]

open access: yesClinicoEconomics and Outcomes Research
Unchalee Permsuwan,1,2 Krit Leemasawat,3 Poukwan Arunmanakul1,2,4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center for Medical and Health Technology Assessment (CM-HTA), Department of ...
Permsuwan U, Leemasawat K, Arunmanakul P
doaj   +2 more sources

Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective [PDF]

open access: yesSaudi Pharmaceutical Journal
Objectives: To perform a budget impact analysis (BIA) of the adoption of baricitinib for the management of alopecia areata (AA) by a Saudi public sector payer.
A. Alshahrani   +6 more
doaj   +2 more sources

PD27 Budget Impact Analysis Of The High-Dose Trivalent Influenza Vaccine For The Brazilian Unified Health System [PDF]

open access: hybridInt J Technol Assess Health Care
Márcia Gisele Costa   +5 more
europepmc   +3 more sources

Transversal Budget Impact Analysis

open access: yes, 2023
109 p. ill., 1 INTRODUCTION 11 -- 1.1 CONTEXT 11 -- 1.2 AIM OF THE STUDY 13 -- 1.2.1 Research questions .13 -- 1.3 METHODS 14 -- 1.3.1 Two case studies 14 -- 1.3.2 Data sources analyzed 14 -- 1.3.3 Methods for the data analysis .15 -- 1.4 REPORT OUTLINE .17 -- 2 BACKGROUND 17 -- 2.1 THE GLOBAL AND PARTIAL BUDGETS OF THE FEDERAL RIZIV-INAMI ...
Camberlin, Cécile   +2 more
openaire   +3 more sources

Good practices for the development of budget impact models at regional level

open access: yesGlobal & Regional Health Technology Assessment, 2023
Introduction: The present work aims to discuss the current scenario of procedures and regulations regarding budget impact analysis/models (BIA/BIM) at regional level in Italy and to provide a standardized approach and detailed recommendations for ...
Andrea Marcellusi   +20 more
doaj   +1 more source

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B

open access: yesGlobal & Regional Health Technology Assessment, 2020
Introduction: Prophylaxis with factor IX (FIX) concentrates, produced by recombinant DNA technology (rFIX) or human plasma-derived concentrates, is the treatment of choice for haemophilia B (HB); rFIX covalently fused to the Fc domain of human ...
Andrea Aiello   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy